ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 224 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $875 | -13.0% | 42 | 0.0% | 0.00% | – |
| Q2 2023 | $1,006 | – | 42 | +110.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 20 | -77.5% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 89 | -3.3% | 0.00% | – |
| Q1 2022 | $2,000 | 0.0% | 92 | -8.0% | 0.00% | – |
| Q4 2021 | $2,000 | -80.0% | 100 | -76.2% | 0.00% | – |
| Q2 2021 | $10,000 | +150.0% | 420 | +172.7% | 0.00% | – |
| Q1 2021 | $4,000 | +33.3% | 154 | +175.0% | 0.00% | – |
| Q4 2020 | $3,000 | +50.0% | 56 | +33.3% | 0.00% | – |
| Q2 2020 | $2,000 | – | 42 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |